A study by Li et al. compared SPRR1A expression at the mRNA level between tumour samples and healthy control tissue and showed that reduced SPRR1A expression in tumour HNSCC samples was associated with a worse prognosis and lower immune infiltration. Here, SPRR1A is linked to neoplasm.